We are live on ! Find out more
TWST icon

Twist Bioscience

245 hedge funds and large institutions have $2.99B invested in Twist Bioscience in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 77 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more call options, than puts

Call options by funds: $5.94M | Put options by funds: $2.02M

19% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 77

0.55% less ownership

Funds ownership: 113.33%112.78% (-0.55%)

6% less funds holding

Funds holding: 262245 (-17)

8% less capital invested

Capital invested by funds: $3.25B → $2.99B (-$264M)

32% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 50

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
92
Reduced
77
Closed
50
Calls
$5.94M
Puts
$2.02M
Net Calls
+$3.91M
Net Calls Change
-$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
X
176
Xponance
Pennsylvania
$212K -$32.1K -675 -13%
Creative Planning
177
Creative Planning
Kansas
$210K -$19.3K -405 -8%
TRCT
178
Tower Research Capital (TRC)
New York
$210K -$186K -3,905 -46%
SOW
179
State of Wyoming
Wyoming
$207K +$218K +4,573 New
Pathstone Holdings
180
Pathstone Holdings
New Jersey
$202K -$65.8K -1,383 -24%
BTI
181
Blue Trust Inc
Georgia
$188K +$125K +2,635 +224%
AWM
182
Ameliora Wealth Management
Switzerland
$172K
A
183
AlphaQuest
New York
$163K -$3.47K -73 -2%
FFA
184
Farther Finance Advisors
California
$154K +$149K +3,134 +1,174%
Russell Investments Group
185
Russell Investments Group
United Kingdom
$141K -$492K -10,332 -77%
Nisa Investment Advisors
186
Nisa Investment Advisors
Missouri
$105K +$2K +42 +2%
Mirae Asset Global Investments
187
Mirae Asset Global Investments
South Korea
$98.3K +$18.1K +381 +22%
CI Investments Inc
188
CI Investments Inc
Ontario, Canada
$95K +$761 +16 +0.8%
BHWM
189
Beaird Harris Wealth Management
Texas
$94.9K +$99.9K +2,100 New
AB
190
Amalgamated Bank
New York
$92K
VFA
191
Virtus Fund Advisers
Connecticut
$78.4K
KBC Group
192
KBC Group
Belgium
$78K
Comerica Bank
193
Comerica Bank
Texas
$63.1K -$26.1K -548 -28%
PNC Financial Services Group
194
PNC Financial Services Group
Pennsylvania
$38.6K -$9.56K -201 -19%
US Bancorp
195
US Bancorp
Minnesota
$37.7K -$7.76K -163 -16%
Acadian Asset Management
196
Acadian Asset Management
Massachusetts
$37K +$39.9K +839 New
IA
197
IFP Advisors
Florida
$36.1K
S
198
SignatureFD
Georgia
$35.8K +$14.6K +306 +63%
WSFS
199
Wilmington Savings Fund Society
Delaware
$34.5K +$36.3K +763 New
FHA
200
First Horizon Advisors
Tennessee
$31.7K -$4.14K -87 -11%

TWST Hedge Fund Activity: Q3 2024 in Review

245 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2024, worth a combined $2.99B — down 8.1% from $3.25B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of TWST and 34 opened new positions — a net loss of 16 holders — while 77 trimmed existing stakes and 92 added.

The largest buyer was Thrivent Financial for Lutherans, opening a new position worth an estimated $46.3M. The largest seller was ARK Investment Management, cutting an estimated $36.7M.

  • 245 institutional investors held Twist Bioscience (TWST) as of Q3 2024, down from 262 in Q2 2024.
  • Funds reported $2.99B of Twist Bioscience stock for Q3 2024, down 8.1% quarter-over-quarter.
  • 34 funds opened new Twist Bioscience positions in Q3 2024 and 50 closed out, a net change of -16 holders.
  • The largest Twist Bioscience buyer in Q3 2024 was Thrivent Financial for Lutherans, an estimated $46.3M added.
  • The largest Twist Bioscience seller in Q3 2024 was ARK Investment Management, an estimated $36.7M sold.

Based on aggregated 13F filings for Q3 2024.